FN1 and acute lymphoblastic leukemia: VLA-5 inhibition with an anti-integrin α5 antibody sufficiently decreased adhesion of the Ph+ ALL cell line SUP-B15 to fibronectin, while a combination of VLA-5 inhibition with imatinib synergistically increased apoptosis in SUP-B15 cells in vitro (185).